First-in-class Histone Deacetylase Inhibitor Gel Shows Promise for the Treatment of Patients with Basal Cell Carcinoma
PHILADELPHIA – Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients...